Erectile Dysfunction: Science and Medicine

References

• Argiolas , A. and Melis , M. R. 2005 . Central control of penile erection: Role of the paraventricular nucleus of the hypothalamus . Progress in Neurobiology , 76 : 1 – 21 .
   PubMed Web of Science ®Google Scholar
• Burnett , A. L. 2003 . Neuroprotection and nerve grafts in the treatment of neurogenic erectile dysfunction . Journal of Urology , 170 : S31 – S34 .
   PubMed Web of Science ®Google Scholar
• Burnett , A. L. 2006 . Erectile dysfunction . Journal of Urology , 175 : S25 – S31 .
   PubMed Web of Science ®Google Scholar
• Burnett , A. L. and Musicki , B. 2005 . The nitric oxide signaling pathway in the penis . Current Pharmaceutical Design , 11 : 3987 – 3994 .
   PubMed Web of Science ®Google Scholar
• Christ , G. J. 1995 . The penis as a vascular organ. The importance of corporal smooth muscle tone in the control of erection . The Urologic Clinics of North America , 22 : 727 – 745 .
   PubMed Web of Science ®Google Scholar
• Christ , G. J. 2000 . Gene therapy: Future strategies and therapies . Drugs Today , 36 : 175 – 184 .
   PubMed Web of Science ®Google Scholar
• Corbin , J. D. 2004 . Mechanisms of action of PDE5 inhibition in erectile dysfunction . International Journal of Impotence Research , 16 ( Suppl. 1 ) : S4 – S7 .
   Google Scholar
• DeBusk , R. , Drory , Y. , Goldstein , I. , Jackson , G. , Kaul , S. Kimmel , S. E. 2000 . Management of sexual dysfunction in patients with cardiovascular disease: Recommendations of the Princeton Consensus Panel . American Journal of Cardiology , 86 : 62F – 68F .
   Web of Science ®Google Scholar
• DiSanto , M. E. 2005 . Contractile mechanisms in diabetes-related erectile dysfunction . Current Pharmaceutical Design , 11 : 3995 – 4010 .
   Google Scholar
• Fournier , G. R. Jr. , Juenemann , K. P. , Lue , T. F. and Tanagho , E. A. 1987 . Mechanisms of venous occlusion during canine penile erection: An anatomic demonstration . Journal of Urology , 137 : 163 – 167 .
   PubMed Web of Science ®Google Scholar
• Guay , A. T. , Perez , J. B. , Jacobson , J. and Newton , R. A. 2001 . Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors . Journal of Andrology , 22 : 793 – 797 .
   PubMed Web of Science ®Google Scholar
• Hatzichristou , D. 2005 . Phosphodiesterase 5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NAION): Coincidence or causality? . Journal of Sexual Medicine , 2 : 751 – 758 .
   PubMed Web of Science ®Google Scholar
• Jackson , G. 2005 . Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors . American Journal of Cardiology , 96 : 32M – 36M .
   Google Scholar
• Jin , L. and Burnett , A. L. 2006 . RhoA/Rho-kinase in erectile tissue: Mechanisms of disease and therapeutic insights . Clinical Science (London) , 110 : 153 – 165 .
   PubMed Web of Science ®Google Scholar
• Kalsi , J. S. , Rees , R. W. , Hobbs , A. J. , Royle , M. , Kell , P. D. Ralph , D. J. 2003 . BAY41–2272, a novel nitric oxide independent soluble guanylate cyclase activator, relaxes human and rabbit corpus cavernosum in vitro . Journal of Urology , 169 : 761 – 766 .
   PubMed Web of Science ®Google Scholar
• Katz , S. D. , Parker , J. D. , Glasser , D. B. , Bank , A. J. , Sherman , N. Wang , H. 2005 . Efficacy and safety of sildenafil citrate in men with erectile dysfunction and chronic heart failure . American Journal of Cardiology , 95 : 36 – 42 .
   PubMed Web of Science ®Google Scholar
• Kirby , M. , Jackson , G. and Simonsen , U. 2005 . Endothelial dysfunction links erectile dysfunction to heart disease . International Journal of Clinical Practice , 59 : 225 – 229 .
   PubMed Web of Science ®Google Scholar
• Kloner , R. A. 2005 . Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: Focus on alpha-blocker interactions . American Journal of Cardiology , 96 : 2M – 46M .
   Google Scholar
• Kloner , R. A. , Jackson , G. , Hutter , A. M. , Mittleman , M. A. , Chan , M. Warner , M. R. 2006 . Cardiovascular safety update to Tadalafil: Retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing . American Journal of Cardiology , 97 : 1778 – 1784 .
   PubMed Web of Science ®Google Scholar
• Kostis , J. B. , Jackson , G. , Rosen , R. , Barrett-Connor , E. , Billups , K. Burnett , A. L. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference) . American Journal of Cardiology . pp. 313 – 321 . 96
   Google Scholar
• Kwon , T. G. , Yoo , J. J. and Atala , A. 2002 . Autologous penile corpora cavernosa replacement using tissue engineering techniques . Journal of Urology , 168 : 1754 – 1758 .
   PubMed Web of Science ®Google Scholar
• Laties , A. and Sharlip , I. 2006 . Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction . Journal of Sexual Medicine , 3 : 12 – 27 .
   PubMed Web of Science ®Google Scholar
• Lue , T. F. , Takamura , T. , Schmidt , R. A. , Palubinskas , A. J. and Tanagho , E. A. 1983 . Hemodynamics of erection in the monkey . Journal of Urology , 130 : 1237 – 1241 .
   PubMed Web of Science ®Google Scholar
• McVary , K. 2006 . Lower urinary tract symptoms and sexual dysfunction: Epidemiology and pathophysiology . British Journal of Urology International , 97 ( Suppl. 2 ) : 23 – 28 .
   Google Scholar
• Melman , A. , Bar-Chama , N. , McCullough , A. , Davies , K. and Christ , G. 2005 . The first human trial for gene transfer therapy for the treatment of erectile dysfunction: Preliminary results . European Urology , 48 : 314 – 318 .
   PubMed Web of Science ®Google Scholar
• Mittleman , M. A. , Glasser , D. B. and Orazem , J. 2003 . Clinical trials of sildenafil citrate (Viagra) demonstrate no increase in risk of myocardial infarction and cardiovascular death compared with placebo . International Journal of Clinical Practice , 57 : 597 – 600 .
   PubMedGoogle Scholar
• Montague , D. K. , Jarow , J. P. , Broderick , G. A. , Dmochowski , R. R. , Heaton , J. P. Lue , T. F. 2005 . Chapter 1: The management of erectile dysfunction: an AUA update . Journal of Urology , 174 : 230 – 239 .
   PubMed Web of Science ®Google Scholar
• Moreland , R. B. , Patel , M. , Hsieh , G. C. , Wetter , J. M. , Marsh , K. and Brioni , J. D. 2005 . A-412997 is a selective dopamine D4 receptor agonist in rats . Pharmacology, Biochemistry, and Behavior , 82 : 140 – 147 .
   PubMed Web of Science ®Google Scholar
• Morelli , A. , Filippi , S. , Mancina , R. , Luconi , M. , Vignozzi , L. Marini , M. 2004 . Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa . Endocrinology , 145 : 2253 – 2263 .
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Impotence . NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence . JAMA . pp. 83 – 90 . 270
   Google Scholar
• Padma-Nathan , H. , Christ , G. , Adaikan , G. , Becher , E. , Brock , G. Carrier , S. 2004 . Pharmacotherapy for erectile dysfunction . Journal of Sexual Medicine , 1 : 128 – 140 .
   PubMed Web of Science ®Google Scholar
• The Process of Care Consensus Panel . 1999 . The process of care model for evaluation and treatment of erectile dysfunction . International Journal of Impotence Research , 11 : 59 – 70 .
   PubMed Web of Science ®Google Scholar
• Rajfer , J. 2004 . Endothelial dysfunction as a cause of erectile dysfunction—Misdiagnosis or misnomer? . Urology , 64 : 193 – 194 .
   Google Scholar
• Rosen , R. C. , Diamond , L. E. , Earle , D. C. , Shadiack , A. M. and Molinoff , P. B. 2004 . Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141, a melanocortin receptor agonist, in healthy male subjects and in patients with an inadequate response to Viagra . International Journal of Impotence Research , 16 : 135 – 142 .
   PubMed Web of Science ®Google Scholar
• de Tejada , I. Saenz , Angulo , J. , Cellek , S. , Gonzalez-Cadavid , N. , Heaton , J. Pickard , R. 2004 . Physiology of erectile dysfunction . Journal of Sexual Medicine , 1 : 254 – 265 .
   Google Scholar
• Shabsigh , R. 2005 . Testosterone therapy in erectile dysfunction and hypogonadism . Journal of Sexual Medicine , 2 : 785 – 792 .
   PubMed Web of Science ®Google Scholar
• Shabsigh , R. , Kaufman , J. M. , Steidle , C. and Padma-Nathan , H. 2004 . Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone . Journal of Urology , 172 : 658 – 663 .
   PubMed Web of Science ®Google Scholar
• Siroky , M. B. and Azadzoi , K. M. 2003 . Vasculogenic erectile dysfunction: Newer therapeutic strategies . Journal of Urology , 170 : S24 – S29 .
   PubMed Web of Science ®Google Scholar
• Thadani , U. , Smith , W. , Nash , S. , Bittar , N. , Glasser , S. Narayan , P. 2002 . The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease . Journal of American College of Cardiology , 40 : 2006 – 2012 .
   PubMed Web of Science ®Google Scholar